These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 9425398

  • 1. Lower cortisol levels after oral glucose in subjects with insulin resistance and abdominal obesity.
    Fernández-Real JM, Ricart W, Casamitjana R.
    Clin Endocrinol (Oxf); 1997 Nov; 47(5):583-8. PubMed ID: 9425398
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Altered adrenocorticotropin and cortisol secretion in abdominal obesity: implications for the insulin resistance syndrome.
    Hautanen A, Adlercreutz H.
    J Intern Med; 1993 Nov; 234(5):461-9. PubMed ID: 8228790
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?
    Brochu M, Tchernof A, Dionne IJ, Sites CK, Eltabbakh GH, Sims EA, Poehlman ET.
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1020-5. PubMed ID: 11238480
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Serum ferritin as a component of the insulin resistance syndrome.
    Fernández-Real JM, Ricart-Engel W, Arroyo E, Balançá R, Casamitjana-Abella R, Cabrero D, Fernández-Castañer M, Soler J.
    Diabetes Care; 1998 Jan; 21(1):62-8. PubMed ID: 9580307
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. ACTH and cortisol response to combined corticotropin releasing hormone-arginine vasopressin stimulation in obese males and its relationship to body weight, fat distribution and parameters of the metabolic syndrome.
    Pasquali R, Gagliardi L, Vicennati V, Gambineri A, Colitta D, Ceroni L, Casimirri F.
    Int J Obes Relat Metab Disord; 1999 Apr; 23(4):419-24. PubMed ID: 10340821
    [Abstract] [Full Text] [Related]

  • 15. Insulin resistance and fat patterning with aging: relationship to metabolic risk factors for cardiovascular disease.
    Cefalu WT, Werbel S, Bell-Farrow AD, Terry JG, Wang ZQ, Opara EC, Morgan T, Hinson WH, Crouse JR.
    Metabolism; 1998 Apr; 47(4):401-8. PubMed ID: 9550536
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Associations between pituitary-adrenocortical function and abdominal obesity, hyperinsulinaemia and dyslipidaemia in normotensive males.
    Hautanen A, Räikkönen K, Adlercreutz H.
    J Intern Med; 1997 Jun; 241(6):451-61. PubMed ID: 10497620
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cortisol metabolism in human obesity: impaired cortisone-->cortisol conversion in subjects with central adiposity.
    Stewart PM, Boulton A, Kumar S, Clark PM, Shackleton CH.
    J Clin Endocrinol Metab; 1999 Mar; 84(3):1022-7. PubMed ID: 10084590
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.